adriamycinol has been researched along with Benign Neoplasms in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cranswick, N; Desai, J; Herschtal, A; Liu, Z; Martin, J; McCowage, G; Michael, M; Nicholls, W; Orme, L; Porter, D; Seddon, B; Sivasuthan, J; Thomas, DM; Thomson, D; Underhill, C; Zacharin, M | 1 |
| Gustafson, DL; Ramirez, D; Weishaar, K; Wittenburg, LA | 1 |
| Boddy, AV; Boos, J; Hempel, G; Kontny, NE; Krischke, M; Völler, S; Würthwein, G | 1 |
| Berg, SL; Bomgaars, LR; Ellis, KJ; Matthay, KK; Moore, TB; Renbarger, J; Rosner, GL; Thompson, PA | 1 |
| Cano, JP; Carcassonne, Y; Durand, A; Favre, R; Gil, P; Iliadis, A | 1 |
| Bartlett, NL; Brophy, NA; Ehsan, MN; Fisher, GA; Halsey, J; Lum, BL; Sikic, BI | 1 |
| Goto, M; Honda, A; Inagaki, J; Kumazawa, T; Ohbayashi, T; Ota, K; Yamanaka, N; Yoshida, H | 1 |
| Bishop, JF; Linahan, BM; Linsenmeyer, ME; Millward, MJ; Olver, IN; Rischin, D; Stokes, KH; Toner, GC; Webster, LK; Woodcock, DM | 1 |
| Andersson, I; Ehrsson, H; Eksborg, S | 1 |
| Bressolle, F; Donadio, D; Galtier, M; Jacquet, JM; Jourdan, J; Rossi, JF | 1 |
| Haase, D; Kittelmann, B; Müller, E; Preiss, R; Sohr, R | 1 |
| Bugat, R; Carton, P; Coulais, Y; Houin, G; Labat, C; Oustrin, J; Sqalli, A | 1 |
| Dale, BM; Green, RM; Kotasek, D; Morris, RG; Reece, PA; Saccoia, NC; Sage, RE | 1 |
| Chauvergne, J; David, M; Huet, S; Robert, J | 1 |
| Rodvold, KA; Rushing, DA; Tewksbury, DA | 1 |
3 trial(s) available for adriamycinol and Benign Neoplasms
| Article | Year |
|---|---|
Age-Dependent Pharmacokinetics of Doxorubicin in Children with Cancer.
Topics: Adolescent; Age Factors; Antibiotics, Antineoplastic; Child; Child, Preschool; Doxorubicin; Female; Humans; Infant; Linear Models; Male; Models, Biological; Neoplasms | 2015 |
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.
Topics: Adult; Aged; Cyclosporine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Humans; Male; Middle Aged; Neoplasms; Treatment Outcome | 1994 |
Phase I trial of cremophor EL with bolus doxorubicin.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Cross-Over Studies; Doxorubicin; Female; Glycerol; Humans; Male; Middle Aged; Neoplasms; Pharmaceutical Vehicles | 1998 |
12 other study(ies) available for adriamycinol and Benign Neoplasms
| Article | Year |
|---|---|
Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood.
Topics: Adolescent; Adult; Age Factors; Antibiotics, Antineoplastic; Bone Neoplasms; Doxorubicin; Female; Hodgkin Disease; Humans; Models, Biological; Neoplasms; Pregnancy; Prospective Studies; Sarcoma, Ewing; Sex Characteristics; Young Adult | 2018 |
Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancers.
Topics: Animals; Antibiotics, Antineoplastic; Area Under Curve; Chromatography, High Pressure Liquid; Colorado; Dog Diseases; Dogs; Doxorubicin; Female; Linear Models; Male; Neoplasms; Neutropenia; Schools, Veterinary | 2019 |
Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study.
Topics: Adolescent; Adult; Antineoplastic Agents; Body Composition; Child; Child, Preschool; Doxorubicin; Female; Humans; Infant; Male; Metabolic Clearance Rate; Neoplasm Staging; Neoplasms; Obesity; Prognosis; Prospective Studies; Treatment Outcome; Young Adult | 2009 |
Time dependency of adriamycin and adriamycinol kinetics.
Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Chromatography, High Pressure Liquid; Doxorubicin; Female; Half-Life; Humans; Kinetics; Male; Middle Aged; Neoplasms; Time Factors | 1983 |
Delayed disposition of adriamycin and its active metabolite in haemodialysis patients.
Topics: Aged; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasms; Renal Dialysis | 1993 |
Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol.
Topics: Chromatography, Liquid; Doxorubicin; Humans; Neoplasms | 1979 |
Doxorubicin and doxorubicinol plasma concentrations and excretion in parotid saliva.
Topics: Adult; Aged; Doxorubicin; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Parotid Gland; Saliva | 1992 |
Investigations on the dose-dependent pharmacokinetics of adriamycin and its metabolites.
Topics: Adult; Aged; Antipyrine; Chromatography, High Pressure Liquid; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasms | 1989 |
Rapid quantitative determination of doxorubicin and its metabolites in biological samples.
Topics: Chromatography, High Pressure Liquid; Daunorubicin; Doxorubicin; Humans; Naphthacenes; Neoplasms; Reference Values | 1989 |
Alteration in doxorubicin and doxorubicinol plasma concentrations with repeated courses to patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasms | 1989 |
Pharmacokinetics and metabolism of pirarubicin in advanced cancer patients.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Doxorubicin; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Uterine Neoplasms | 1988 |
Doxorubicin clearance in the obese.
Topics: Body Weight; Chromatography, High Pressure Liquid; Doxorubicin; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Obesity | 1988 |